Why the study?
Does pharmacist involvement in transitions of care reduce 30-day all-cause inpatient readmissions and ED visits in high-risk internal medicine patients?
Population
278 patients admitted to 2 designated internal medicine units on high-risk medications or with greater than…
Comparison
Face-to-face medication reconciliation, a… vs Usual hospital standard of care
Design
RCT, randomized
Follow-up
30 days postdischarge
Authors
Loading...
Supports pharmacist involvement in transitions of care; confirms reduction in 30-day readmissions and ED visits among high-risk patients.
Does pharmacist involvement in transitions of care reduce 30-day all-cause inpatient readmissions and ED visits in high-risk internal medicine patients?
Pharmacist involvement in hospital discharge transitions of care significantly decreases composite 30-day inpatient readmissions and ED visits in high-risk patients.
Phatak et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: